Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Pneumonia

1-methyl-3-isobutylxanthine has been researched along with Pneumonia in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Pneumonia: Infection of the lung often accompanied by inflammation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lee, CD1
Choi, WS1
Choi, YG1
Kang, HS1
Lee, WT1
Kim, HJ1
Lee, JY1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Pneumonia

ArticleYear
Inhibition of phosphodiesterase suppresses allergic lung inflammation by regulating MCP-1 in an OVA-induced asthma murine model with co-exposure to lipopolysaccharide.
    The Journal of international medical research, 2020, Volume: 48, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Administration, Inhalation; Airway Resistance; Animals; Asthma; Broncho

2020